NCT05833932View on ClinicalTrials.gov

Suhexiang Pill for Acute Ischemic Stroke: A Registry Study

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ischemic Stroke
Interventions
DRUG

Suhexiang Pill

Suhexiang Pill is an approved traditional Chinese patent medicine.

Trial Locations (2)

100700

NOT_YET_RECRUITING

Dongzhimen Hospital, Beijing

RECRUITING

Dongzhimen Hospital, Beijing

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER